1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Roesch, P.
Seidel, G.
Schaefer, W.
Esswein, A.
Hofmann, E.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C6 H13 N O2
131.173
n
NORLEUCINE
L-peptide linking
C5 H12 N2 O2
132.161
n
L-ornithine
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
NE
Febs Lett.
FEBLAL
0165
0014-5793
444
239
244
10.1016/S0014-5793(98)01658-5
10050767
The structure of human parathyroid hormone-related protein(1-34) in near-physiological solution.
1999
10.2210/pdb1hth/pdb
pdb_00001hth
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
4116.704
CYCLIC PARATHYROID HORMONE
RESIDUES 1-34
M8NLE, K13ORN, S17E, M18NLE
1
man
polymer
no
yes
SVSEIQL(NLE)HNLG(ORN)HLNE(NLE)ERVEWLRKKLQDVHNF
SVSEIQLLHNLGAHLNELERVEWLRKKLQDVHNF
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
HUMAN
sample
Homo sapiens
database_2
pdbx_database_status
struct_conn
struct_ref_seq_dif
repository
Initial release
Version format compliance
Non-polymer description
Version format compliance
Database references
Derived calculations
Other
1
0
1997-10-15
1
1
2008-03-24
1
2
2011-07-13
1
3
2021-11-03
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
_struct_conn.pdbx_leaving_atom_flag
_struct_conn.ptnr1_auth_comp_id
_struct_conn.ptnr1_auth_seq_id
_struct_conn.ptnr1_label_atom_id
_struct_conn.ptnr1_label_comp_id
_struct_conn.ptnr1_label_seq_id
_struct_conn.ptnr2_auth_comp_id
_struct_conn.ptnr2_auth_seq_id
_struct_conn.ptnr2_label_atom_id
_struct_conn.ptnr2_label_comp_id
_struct_conn.ptnr2_label_seq_id
_struct_ref_seq_dif.details
Y
BNL
1997-04-09
REL
REL
ENERGY, AGREEMENT WITH EXPERIMENTAL DATA
50
10
5.0
298
K
SIMULATED ANNEALING, RESTRAINED MOLECULAR DYNAMICS
BRUNGER
refinement
X-PLOR
3.1
structure solution
NDEE
structure solution
X-PLOR
600
Bruker
AMX600
SER
1
n
1
SER
1
A
VAL
2
n
2
VAL
2
A
SER
3
n
3
SER
3
A
GLU
4
n
4
GLU
4
A
ILE
5
n
5
ILE
5
A
GLN
6
n
6
GLN
6
A
LEU
7
n
7
LEU
7
A
NLE
8
n
8
NLE
8
A
HIS
9
n
9
HIS
9
A
ASN
10
n
10
ASN
10
A
LEU
11
n
11
LEU
11
A
GLY
12
n
12
GLY
12
A
ORN
13
n
13
ORN
13
A
HIS
14
n
14
HIS
14
A
LEU
15
n
15
LEU
15
A
ASN
16
n
16
ASN
16
A
GLU
17
n
17
GLU
17
A
NLE
18
n
18
NLE
18
A
GLU
19
n
19
GLU
19
A
ARG
20
n
20
ARG
20
A
VAL
21
n
21
VAL
21
A
GLU
22
n
22
GLU
22
A
TRP
23
n
23
TRP
23
A
LEU
24
n
24
LEU
24
A
ARG
25
n
25
ARG
25
A
LYS
26
n
26
LYS
26
A
LYS
27
n
27
LYS
27
A
LEU
28
n
28
LEU
28
A
GLN
29
n
29
GLN
29
A
ASP
30
n
30
ASP
30
A
VAL
31
n
31
VAL
31
A
HIS
32
n
32
HIS
32
A
ASN
33
n
33
ASN
33
A
PHE
34
n
34
PHE
34
A
author_defined_assembly
1
monomeric
A
NLE
8
NORLEUCINE
A
NLE
8
LEU
A
ORN
13
ORNITHINE
A
ORN
13
ALA
A
NLE
18
NORLEUCINE
A
NLE
18
LEU
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
ARG
20
0.136
SIDE CHAIN
1
A
ARG
25
0.311
SIDE CHAIN
2
A
ARG
20
0.259
SIDE CHAIN
2
A
ARG
25
0.282
SIDE CHAIN
3
A
ARG
20
0.276
SIDE CHAIN
3
A
ARG
25
0.302
SIDE CHAIN
4
A
ARG
20
0.276
SIDE CHAIN
4
A
ARG
25
0.301
SIDE CHAIN
5
A
ARG
20
0.236
SIDE CHAIN
5
A
ARG
25
0.300
SIDE CHAIN
6
A
ARG
20
0.186
SIDE CHAIN
6
A
ARG
25
0.309
SIDE CHAIN
7
A
ARG
20
0.185
SIDE CHAIN
7
A
ARG
25
0.317
SIDE CHAIN
8
A
ARG
20
0.229
SIDE CHAIN
8
A
ARG
25
0.260
SIDE CHAIN
9
A
ARG
20
0.254
SIDE CHAIN
9
A
ARG
25
0.266
SIDE CHAIN
10
A
ARG
20
0.216
SIDE CHAIN
10
A
ARG
25
0.274
SIDE CHAIN
1
A
ILE
5
-89.16
32.51
1
A
ORN
13
-129.15
-53.62
1
A
HIS
14
168.84
128.17
1
A
NLE
18
-145.47
25.06
1
A
GLU
19
-83.72
-77.26
1
A
VAL
31
37.18
96.35
1
A
HIS
32
-53.76
87.23
2
A
ILE
5
-91.16
37.90
2
A
LEU
11
-85.00
-87.85
2
A
ORN
13
61.18
121.98
2
A
HIS
14
-127.95
-122.75
2
A
GLU
22
-70.84
-70.37
2
A
LYS
26
-76.96
-165.16
2
A
LYS
27
61.36
-88.81
2
A
GLN
29
-46.01
101.87
2
A
ASP
30
178.99
-38.94
2
A
VAL
31
40.93
26.68
2
A
HIS
32
39.05
50.44
2
A
ASN
33
-92.56
30.61
3
A
ORN
13
32.49
40.90
3
A
HIS
14
74.44
127.09
3
A
NLE
18
-96.63
30.89
3
A
LYS
26
-80.11
37.11
3
A
ASP
30
-100.71
53.14
4
A
SER
3
-86.52
40.31
4
A
GLN
6
-158.48
-50.70
4
A
ORN
13
77.68
-4.40
4
A
HIS
14
72.40
134.77
4
A
LEU
28
80.01
-7.61
4
A
HIS
32
-161.41
55.35
4
A
ASN
33
166.19
-76.72
5
A
VAL
2
53.04
-177.95
5
A
ILE
5
-93.43
32.27
5
A
HIS
14
-74.21
-97.29
5
A
LYS
26
-98.46
37.08
5
A
VAL
31
172.47
87.51
5
A
HIS
32
-166.55
38.44
5
A
ASN
33
-102.26
-77.82
6
A
VAL
2
-63.40
-169.89
6
A
ILE
5
-91.00
37.78
6
A
ORN
13
-127.91
-51.81
6
A
LYS
26
-83.66
44.94
6
A
LYS
27
-143.07
-47.46
6
A
VAL
31
-91.14
59.13
6
A
HIS
32
178.56
-37.04
6
A
ASN
33
70.18
94.91
7
A
VAL
2
44.08
-171.97
7
A
ILE
5
-91.30
41.71
7
A
ORN
13
84.69
-33.23
7
A
HIS
14
78.74
145.43
7
A
LEU
24
-32.57
-35.73
7
A
GLN
29
-88.18
39.73
7
A
HIS
32
67.92
67.47
8
A
SER
3
-56.74
100.04
8
A
ORN
13
43.26
29.44
8
A
HIS
14
73.60
137.46
8
A
LEU
15
-85.20
31.31
8
A
LEU
24
-33.39
-32.24
8
A
GLN
29
-159.84
30.23
8
A
VAL
31
70.52
108.02
8
A
HIS
32
-134.08
-79.20
9
A
GLU
4
-94.37
-77.93
9
A
ASN
10
-84.49
-70.38
9
A
HIS
14
-75.99
-131.85
9
A
LYS
26
-78.45
36.61
9
A
LEU
28
-143.53
15.39
9
A
VAL
31
40.75
29.71
10
A
ILE
5
-75.72
-163.98
10
A
GLN
6
80.03
-71.40
10
A
LEU
11
176.82
50.01
10
A
ORN
13
-165.86
-112.96
10
A
HIS
14
176.38
142.74
10
A
GLU
22
-65.97
-71.18
10
A
LEU
24
-39.76
-30.04
10
A
VAL
31
70.43
129.34
10
A
ASN
33
36.28
87.96
model building
X-PLOR
3.1
refinement
X-PLOR
3.1
phasing
X-PLOR
3.1
The solution structure of cyclic human parathyroid hormone fragment 1-34, NMR, 10 structures
1
Y
N
A
GLU
4
A
GLU
4
HELX_P
A
GLN
6
A
GLN
6
5
1
3
A
ARG
20
A
ARG
20
HELX_P
A
GLN
29
A
GLN
29
1
2
10
covale
1.291
both
A
LEU
7
A
C
LEU
7
1_555
A
NLE
8
A
N
NLE
8
1_555
covale
1.307
both
A
NLE
8
A
C
NLE
8
1_555
A
HIS
9
A
N
HIS
9
1_555
covale
1.305
both
A
GLY
12
A
C
GLY
12
1_555
A
ORN
13
A
N
ORN
13
1_555
covale
1.306
both
A
ORN
13
A
C
ORN
13
1_555
A
HIS
14
A
N
HIS
14
1_555
covale
1.306
one
A
ORN
13
A
NE
ORN
13
1_555
A
GLU
17
A
CD
GLU
17
1_555
covale
1.304
both
A
GLU
17
A
C
GLU
17
1_555
A
NLE
18
A
N
NLE
18
1_555
covale
1.303
both
A
NLE
18
A
C
NLE
18
1_555
A
GLU
19
A
N
GLU
19
1_555
HORMONE
HUMAN PARATHYROID HORMONE, CYCLIC, ORNITHINE, NORLEUCINE, HORMONE
PTHY_HUMAN
UNP
1
1
P01270
MIPAKDMAKVMIVMLAICFLTKSDGKSVKKRSVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNFVALGAPLAPRDAGSQ
RPRKKEDNVLVESHEKSLGEADKADVNVLTKAKSQ
32
65
1HTH
1
34
P01270
A
1
1
34
1
MET
engineered mutation
NLE
8
1HTH
A
P01270
UNP
39
8
1
LYS
engineered mutation
ORN
13
1HTH
A
P01270
UNP
44
13
1
SER
engineered mutation
GLU
17
1HTH
A
P01270
UNP
48
17
1
MET
engineered mutation
NLE
18
1HTH
A
P01270
UNP
49
18
1
P 1